Vitale, Candida
Griggio, Valentina
Todaro, Maria
Riganti, Chiara
Jones, Rebecca
Boccellato, Elia
Perutelli, Francesca
Arruga, Francesca
Vaisitti, Tiziana
Efremov, Dimitar G.
Deaglio, Silvia
Landesman, Yosef
Bruno, Benedetto
Coscia, Marta
Funding for this research was provided by:
AIRC (IG15232, IG21408, IG23095)
Karyopharm Therapeutics (UNITO-CLL01)
University of Torino (Local funds ex60%)
Article History
Received: 26 April 2023
Accepted: 3 October 2023
First Online: 7 October 2023
Competing interests
: C.V. has received consultancy fees from Abbvie, Janssen and Astra Zeneca. Y.L. was an employee of Karyopharm Therapeutics Inc. M.C. received honoraria from Janssen, Gilead, Abbvie, Shire, Astrazeneca and research support from Janssen, Abbvie and Karyopharm Therapeutics. The remaining authors declare no conflict of interest.